Schedule 13G ownership disclosure

DOR BIOPHARMA INC

Security class unavailable · CUSIP: 258094101

Event date: 2016-12-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
345,191
Percent of class
5.8100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-17-000716
Form type
SC 13G
Filer
SC Fundamental Value Fund, L.P.
CIK
CIK 1322318
Filed
Oct 12, 2017
Reporting period
Dec 13, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub